Delivery Order SPE2DB22D3401-SPE2DB25FT6CF
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.52 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract involves the delivery of a corticosteroid medication commonly utilized across military and federal...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dexamethasone 20 mg/5 ml vials in 5 ml quantities, with a ceiling value of $1,046.46. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dexamethasone 0.5 mg/5 mL elixir in 237 mL quantities, with a ceiling value of $3,838.74. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The pharmaceutical will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dexamethasone 10 mg/ml vials with a ceiling value of $4,116.72 and a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,343.25. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.80 to AmerisourceBergen Drug Corp for Dexamethasone 4 mg tablets in unit dose packages of 100 units. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used across military and federal...
- This is a $6,618.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 237 mL vials of the medication dexamethasone 0.5 mg/5 mL, a steroid used to treat a variety of conditions. The award is not set aside and has an ultimate completion date of June 16, 2025. AmerisourceBergen Drug Corporation is the prime contractor and holds a larger $999,999,999.00...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,113.35 for 100 tablets of Dexamethasone 4 mg, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, employs firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6CFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,660.78. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 11, 2025, and performance to be executed from the vendor's location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used in military and federal healthcare settings for treating inflammation and other medical conditions. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and other government healthcare systems. The company's contract awards demonstrate consistent performance across competitively awarded delivery orders with firm fixed pricing, reflecting its capability to meet federal procurement requirements for essential medications and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/10/25 |